Loading
thyssenkrupp nucera AG & Co. KGaA Stock: price and insider trades · Germany
No insider purchase over the last 90 days. The latest was filed 18 Feb 2026.
thyssenkrupp nucera AG & Co. KGaA: what insiders have been doing
This page follows insider dealings at thyssenkrupp nucera AG & Co. KGaA as filed with BaFin, a company from the Chemicals & Materials sector based in Dortmund, Germany. The group dates from 1960. Between 18 October 2025 and 18 October 2026, 4 insiders published 6 filings.
No insider sold shares on the market over the period. Instead, the filings list 6 purchases totalling €31k, made by 4 insiders. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Ponikwar, Dr. Werner filed the largest purchase, €10k, on 17 February 2026. The buyers include 4 senior executives.
Within a 30-day window, 5 purchases overlapped with buying by a second insider. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. The most recent open-market purchase was published on 18 February 2026, 241 days ago. Between a trade and the moment it shows up on BaFin, the median delay is 5 days. For comparison, MAR article 19 gives managers three business days to notify a trade.
Across the 287 companies tracked on its exchange, the median is 5 filings; at 6 filings, this issuer sits above that mark. Our records for thyssenkrupp nucera AG & Co. KGaA go back to 2026, with 6 purchases and no sales on the open market in total.
Elsewhere in the same sector, our signals recently picked up insider purchases at Culp Inc. Source: insider filings from BaFin. Past trades are no guide to future returns.
Key facts
Headquarters: Dortmund, Germany · Founded: 1960
Source: Wikidata (CC0).
Insider Decl.
6
Thresholds
n/a
Buy Volume
€31,163
6 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleDr. Stefan Hahn3 buys
Dr. Werner Ponikwar2 buys
Klaus Ohlig2 buys
Since the insiders bought
- -10.6%Entry €9.31 · Close 14 Oct 2026 €8.32
- -10.6%Entry €9.31 · Close 14 Oct 2026 €8.32
- -10.6%Entry €9.31 · Close 14 Oct 2026 €8.32
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate thyssenkrupp nucera AG & Co. KGaA Hold (neutral), based on 10 analysts. Average price target: €10.52.
Fundamental score
Ranked 19,243 of 24,148 companies
31.1
score / 100
Value30
Quality32
FCF yld1.1%
Earn yld0.5%
EV/EBITDA31.8x
ROE-8.8%
Gross mgn13%
Net mgn0.5%
Debt/EBITDA0.9x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended September 2025 · cache
€7.91
Analyst consensus
10 analystsHold
€8.00Target €10.52(+33%)€15.00
Income statement
Revenue€845.2M
Gross profit€112.2M13% margin
EBITDA€32.3M4% margin
Net income€4.6M-11.8% margin
Valuation
PER (forward)53.6x
P/Book1.4x
Beta1.12
Balance sheet & cash
Market cap€999.2M
Total debt€28.2M
Free Cash Flow€10.8M
Debt / Equity4%
Profitability & ownership
ROE-8.8%
ROA-3.7%
% insiders76.0%
% institutions8.7%
Last declaration on 18 February 2026
Declarations6 total
171.943 shares@ €9.0648.9% of flowShareXetraISIN DE000NCA0001BAFIN:40032823-eba4ac317109
Canonical exit: 14 May 2026 (T+90)
401.866 shares@ €9.0648.9% of flowShareXetraISIN DE000NCA0001BAFIN:40032823-08d6911fc5ce
Canonical exit: 14 May 2026 (T+90)
1,107.632 shares@ €9.0648.9% of flowShareXetraISIN DE000NCA0001BAFIN:40032823-3535b22cedcd
Canonical exit: 14 May 2026 (T+90)
175 shares@ €9.3151.1% of flowShareXetraISIN DE000NCA0001BAFIN:40032823-6315f5d0a4a8
Canonical exit: 13 May 2026 (T+90)
1,127.002 shares@ €9.3151.1% of flowShareXetraISIN DE000NCA0001BAFIN:40032823-37d62beaca0f
Canonical exit: 13 May 2026 (T+90)
409.001 shares@ €9.3151.1% of flowShareXetraISIN DE000NCA0001BAFIN:40032823
Canonical exit: 13 May 2026 (T+90)
6 of 6 declarations
About thyssenkrupp nucera AG & Co. KGaA
thyssenkrupp nucera AG & Co. KGaA is an industrial engineering company listed on Xetra/Frankfurt (DAX/MDAX/SDAX) in Germany, with its headquarters in Dortmund. The group is focused on electrolysis technologies serving both the chemicals industry and the energy transition. Its technological roots go back decades through thyssenkrupp’s historical electrolysis activities and the expertise inherited from Chlorine Engineers/De Nora. The company became a standalone, listed platform for electrolysis and completed its IPO in July 2023.
The business is organized around two core segments. Green Hydrogen provides alkaline water electrolysis systems used by industrial and energy customers to produce green hydrogen at scale. Chlor-Alkali supplies membrane electrolysis technologies for the production of chlorine, caustic soda and related chemical intermediates, along with associated hydrochloric acid applications. The portfolio includes BiTAC, BM and ODC technologies, plus lifecycle services, engineering support and EPC project execution. A key strategic theme is standardization and modularization, designed to improve industrial repeatability, project delivery speed and cost efficiency.
Read moreShow less
From a competitive perspective, thyssenkrupp nucera is one of the leading global names in alkaline electrolysis and chlor-alkali membrane electrolysis. Its market position is supported by a sizeable installed base, long project execution experience and a reputation for handling large industrial plants. The company competes on technology reliability, engineering capabilities and the ability to deliver utility-scale projects across multiple geographies. Its customer base is international, spanning Europe, the Middle East, Asia and other major industrial regions.
Recent developments have been notable. In 2025/2026, the company reported a sharp improvement in order intake, driven in part by a major green hydrogen contract for Moeve in Spain, described by the company as Southern Europe’s largest green hydrogen project, as well as new chlor-alkali orders. It also expanded its technology portfolio through the acquisition of key technology assets from Green Hydrogen Systems and advanced initiatives in high-temperature electrolysis and lifecycle services. For investors, thyssenkrupp nucera remains a pure-play industrial decarbonization and process-technology story, with exposure both to the chemical cycle and to the gradual commercialization of green hydrogen.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
